Biotechnology - Printing the Largest Human Protein Array
Can't see this email? View it online
   
  Biotechnology  
  The latest Biotechnology news from AZoNetwork  
 

Assays and Technologies for Studying RAS Biology Assays and Technologies for Studying RAS Biology

As the most frequently mutated oncogene in human cancers, RAS is a key target in drug discovery. Find a suite of tools and techniques available for studying modulators of the RAS pathway, including live-cell assays that measure target engagement on RAS complexes, protein:protein interactions and more.

Learn More
 
 
    Printing the Largest Human Protein Array Printing the Largest Human Protein Array
 
Arrayjet Advance™ manufacturing services worked with a prominent US-based proteomics company to improve its protein array production and enhance its yield while minimizing sample waste.
 
Read the Article Now
 
 
   Researchers use bacteria to create artificial cells that function like living cellsResearchers use bacteria to create artificial cells that function like living cells
 
Researchers have used bacteria to create sophisticated synthetic cells that imitate the activity of genuine cells.
 
   Using Decellularized Extracellular Matrix as a BiomaterialUsing Decellularized Extracellular Matrix as a Biomaterial
 
In a paper recently published in the journal Biomaterials, researchers examined the challenges, synthesis techniques, and advances made in the development of decellularized extracellular matrix (dECM)-based biomaterials to imitate specific physical and biological characteristics of native tissue.
 
   MD Anderson and Virogin Biotech collaborate to advance the development of investigational oncolytic viruses, treatmentsMD Anderson and Virogin Biotech collaborate to advance the development of investigational oncolytic viruses, treatments
 
The University of Texas MD Anderson Cancer Center and Virogin Biotech today announced a strategic collaboration to accelerate the development of investigational treatments, including oncolytic viruses and immunotherapies, for patients with advanced cancers.
 
   First nasal vaccine for COVID-19 approved in India for emergency useFirst nasal vaccine for COVID-19 approved in India for emergency use
 
The world's first nasal vaccine for COVID-19 was approved Tuesday, Sept. 6, in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University in St. Louis and developed in collaboration with Bharat Biotech International Limited in India.